skip to main content
Idioma:
Tipo de recurso Mostra resultados com: Mostra resultados com: Índice

Modulation of T Cell Function by Combination of Epitope Specific and Low Dose Anticytokine Therapy Controls Autoimmune Arthritis

Roord, Sarah TA ; Zonneveld-Huijssoon, Evelien ; Le, Tho ; Yung, Gisella Puga ; Koffeman, Eva ; Ronaghy, Arash ; Ghahramani, Negar ; Lanza, Paola ; Billetta, Rosario ; Prakken, Berent J ; Albani, Salvatore

PloS one, 2006-01, Vol.1 (1) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
  • Título:
    Modulation of T Cell Function by Combination of Epitope Specific and Low Dose Anticytokine Therapy Controls Autoimmune Arthritis
  • Autor: Roord, Sarah TA ; Zonneveld-Huijssoon, Evelien ; Le, Tho ; Yung, Gisella Puga ; Koffeman, Eva ; Ronaghy, Arash ; Ghahramani, Negar ; Lanza, Paola ; Billetta, Rosario ; Prakken, Berent J ; Albani, Salvatore
  • É parte de: PloS one, 2006-01, Vol.1 (1)
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    content type line 23
    ObjectType-Feature-2
  • Descrição: Innate and adaptive immunity contribute to the pathogenesis of autoimmune arthritis by generating and maintaining inflammation, which leads to tissue damage. Current biological therapies target innate immunity, eminently by interfering with single pro-inflammatory cytokine pathways. This approach has shown excellent efficacy in a good proportion of patients with Rheumatoid Arthritis x28; RAx29; , but is limited by cost and side effects. Adaptive immunity, particularly T cells with a regulatory function, plays a fundamental role in controlling inflammation in physiologic conditions. A growing body of evidence suggests that modulation of T cell function is impaired in autoimmunity. Restoration of such function could be of significant therapeutic value. We have recently demonstrated that epitope-specific therapy can restore modulation of T cell function in RA patients. Here, we tested the hypothesis that a combination of anti-cytokine and epitope-specific immunotherapy may facilitate the control of autoimmune inflammation by generating active T cell regulation. This novel combination of mucosal tolerization to a pathogenic T cell epitope and single low dose anti-TNF alpha was as therapeutically effective as full dose anti-TNF alpha treatment. Analysis of the underlying immunological mechanisms showed induction of T cell immune deviation.
  • Idioma: Inglês
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.